Skip to main content
Equibles

Kevin DeJeter

Analyst

Lindeberg-Thalman

Equibles does not estimate personal net worth.

About Kevin DeJeter

Kevin DeJeter is recorded as Analyst at Lindeberg-Thalman. Kevin DeJeter has spoken on 1 earnings call across 1 company, most recently for NovoCure Ltd on October 29, 2026. The companies whose calls Kevin DeJeter spoke on are classified in the Healthcare sector.

Kevin DeJeter on recent calls

“I actually had one on the Veristem collaboration or clinical trial you announced yesterday. And from the NovoCure perspective, what's the more important learning from that study?”
Analyst — Lindeberg-Thalman, Q3 2026 Earnings Conference Call ·

Affiliation history

  • Lindeberg-Thalman

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity